Sector ratings Dr. Lal PathLabs Limited

Stocks

Delayed NSE India S.E. Other stock markets 12:04:47 2026-07-14 am EDT			5-day change	1st Jan Change
1,748.20 ^INR	+1.34%		+4.09%	+18.00%

Jun. 17	Dr. Lal PathLabs' Volume Boom Comes at a Cost
May. 04	Nomura Adjusts Dr. Lal PathLabs' Price Target to INR1,860 From INR1,800, Keeps at Buy	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation	Visibility
DR. LAL PATHLABS LIMITED	2.97B		A
NATERA, INC.	38.66B	-	BB	-	-
LABCORP HOLDINGS INC.	22.7B		AA
SONIC HEALTHCARE LIMITED	7.3B		AA
RADNET, INC.	5.16B	-	A	-	-
GENEDX HOLDINGS CORP.	1.95B	-	BBB	-	-
DIAN DIAGNOSTICS GROUP CO.,LTD.	1.84B		-
NEOGENOMICS, INC.	1.84B	-	AA	-	-
FLEURY S.A.	1.75B		AA
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	1.68B		AA
VIJAYA DIAGNOSTIC CENTRE LIMITED	1.5B		-
METROPOLIS HEALTHCARE LIMITED	1.23B		BBB
H.U. GROUP HOLDINGS, INC.	1.15B		AAA
OPKO HEALTH, INC.	1.02B	-	BBB	-	-
THYROCARE TECHNOLOGIES LIMITED	861M	-	-	-	-
BML, INC.	848M	-	AA	-	-	-
NOVOGENE CO., LTD.	784M		-		-
ARTRYA LIMITED	641M	-	-	-	-
SMO CLINPLUS CO.,LTD.	585M	-	-	-	-	-
FULGENT GENETICS, INC.	584M	-	AA	-	-	-
Average	4.75B		AA
Weighted average by Cap.			AA